Influenza

>

Latest News

GSK mRNA Flu Vaccine Candidate Delivers Favorable Topline Phase 2 Findings, Ready for Phase 3 / image credit GSK logo: ©desertsands/stock.adobe.com
GSK mRNA Flu Vaccine Candidate Delivers Favorable Topline Phase 2 Findings, Ready for Phase 3

September 12th 2024

The GSK reformulation induced acceptable immune responses for both influenza A and B strains, overcoming a setback earlier in the ability to successfully neutralize the latter.

Respiratory Virus Vaccines: A Q&A With AAFP President Steven Furr, MD
Respiratory Virus Vaccines: A Q&A With AAFP President Steven Furr, MD

August 23rd 2024

Intranasal Flu Vaccine Coadministered with High-Dose Shot More Effective in Older Adults than Shot Alone / image credit influenza virus: ©Kateryna Kon/stock.adobe.com
Intranasal Flu Vaccine Coadministered with High-Dose Shot More Effective in Older Adults than Shot Alone

July 15th 2024

CDC Updates COVID-19, Influenza Vaccine Recommendations for 2024-2025 Respiratory Virus Season
CDC Updates COVID-19, Influenza Vaccine Recommendations for 2024-2025 Respiratory Virus Season

June 28th 2024

Video Interviews
Podcasts

More News

© 2024 MJH Life Sciences

All rights reserved.